Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders

Neuropsychopharmacology

Volumn 18, Issue 4, 1998, Pages 253-262

  Modell, Sieglinde ^a   Lauer, Christoph Johannes ^a   Schreiber, Wolfgang ^b   Huber, Johannes ^a   Krieg, Jürgen Christian ^b   Holsboer, Florian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Affective disorders; Corticotropin; Dexamethasone CRH test; Vulnerability

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DEPRESSION; DISEASE PREDISPOSITION; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE RELEASE; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PROVOCATION TEST;

ADRENOCORTICOTROPIC HORMONE; ADULT; AREA UNDER CURVE; CORTICOTROPIN-RELEASING HORMONE; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HORMONES; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; MOOD DISORDERS; NEUROSECRETORY SYSTEMS; RISK FACTORS;

EID: 0031885081     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00144-9     Document Type: Article

References (43)

1. Arana GW, Baldessarini RJ, Ornsteen M The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch Gen Psychiatry. 42:1991;1193-1204.
2. Bardeleben von U, Holsboer F, Stalla GK, Müller OA Combined administration of human corticotropin-releasing factor and vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci. 37:1985;1613-1618.
3. Bardeleben von U, Holsboer F Cortisol response to a combined dexamethasone-human corticotropin-releasing hormone challenge in patients with depression. J Neuroendocrinol. 1:1989;485-488.
4. Bardeleben von U, Holsboer F Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients with dexamethasone. Biol Psychiatry. 29:1991;1042-1050.
5. Bertelsen A, Harvald B, Hauge M A Danish twin study of manic-depressive disorder. Br J Psychiatry. 130:1977;330-351.
6. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James N, Kronfol Z, Lohr N, Steiner M, De Vigne JP, Young E A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry. 38:1981;15-22.
7. Coryell W, Zimmerman M HPA-axis abnormalities in psychiatrically well controls. Psychiatry Res. 20:1987;265-273.
8. Crowe RR, Noyes R, Pauls DL, Slymen D A family study of panic disorder. Arch Gen Psychiatry. 40:1983;1065-1069.
9. Fink G, Rosie R, Sheward WJ, Thomson E, Wilson H Steroid control of neuronal interactions and function. J Steroid Biochem Mol Biol. 40:1991;123-132.
10. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, Augerinos P, Paul S, Oldfield EH, Cutler GB, Chrousos GP Response to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med. 314:1986;1329-1335.
11. Hermus ARM, Pieters GFF, Pesman GJ, Smals AGH, Benraad TJ, Kloppenburg PWC Responsivity of adrenocorticotropin to corticotropin- releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease. J Clin Endocrinol Metab. 62:1986;634-639.
12. Heuser I, Yassouridis A, Holsboer F The combined dexamethasone/CRH test. A refined laboratory test for psychiatric disorders J Psychiatr Res. 28:1994;341-356.
13. Heuser IJ, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, Yassouridis A, Holsboer F Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J Psychiatry. 153:1996;93-99.
14. Holsboer F, Gerken A, von Bardeleben U, Grimm W, Beyer H, Müller OA, Stalla GK Human corticotropin-releasing hormone in depression. Biol Psychiatry. 18:1986;911-916.
15. Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression Biol Psychiatry. 22:1987;228-234.
16. Holsboer F, Lauer CJ, Schreiber W, Krieg J-C Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology. 62:1995;340-347.
17. Holsboer-Trachsler E, Stohler R, Hatzinger M Repeated administration of the combined dexamethasone/hCRH stimulation test during treatment of depression. Psychiatry Res. 38:1991;163-171.
18. Holsboer-Trachsler E, Hemmeter U, Hatzinger M, Seifritz E, Gerhard U, Hobi V Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment - neurobiological and psychometric assessment of course. J Psychiatr Res. 28:1994;381-399.
19. Kendler KS, Perdersen N, Johnson L, Neale MC, Mathe AA A pilot Swedish twin study of affective illness, including hospital- and population-ascertained subsamples. Arch Gen Psychiatry. 50:1993;699-706.
20. Kendler KS, Walters EE, Truett KR, Heath AC, Neale MC, Martin NG, Eaves LJ Sources of individual differences in depressive symptoms. Analysis of two samples of twins and their families Am J Psychiatry. 151:1994;1605-1614.
21. Kirschbaum C, Wüst S, Faig H-G, Hellhammer DH Heritability of cortisol responses to human corticotropin-releasing hormone, ergometry, and psychological stress in humans. J Clin Endocrinol Metab. 75:1992;1526-1530.
22. Lauer CJ, Schreiber W, Holsboer F, Krieg J-C In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatry. 52:1995;145-153.
23. Lauer CJ, Bronisch T, Kainz M, Schreiber W, Holsboer F, Krieg J-C Premorbid psychometric profil of subjects at high familial risk for affective disorders. Psychol Med. 27:1997;355-364.
24. Mason JW A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosom Med. 30:1968;576-607.
25. Maxwell JD, Boyle JA, Greig WR, Buchanan WW Plasma corticosteroids in healthy twin pairs. J Med Genet. 6:1969;294-297.
26. Meikle AW, Stringham JD, Woodward MG, Bishop DT Heritability of variation of plasma cortisol levels. Metabolism. 37:1988;514-517.
27. Merikangas KR, Spence MA, Kupfer DJ Linkage studies of bipolar disorder. Methodologic and analytic issues Arch Gen Psychiatry. 46:1989;1137-1141.
28. Modell S, Yassouridis A, Huber J, Holsboer F Corticosteroid function decreased in depressed patients. Neuroendocrinology. 65:1997;216-222.
29. Montkowski A, Barden N, Wotjak C, Stec I, Ganster J, Meaney M, Engelmann M, Reul JMHM, Landgraf R, Holsboer F Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol. 7:1995;841-845.
30. Post M Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 149:1992;999-1010.
31. Purba JS, Witte JG, Hoogendijk WJG, Hofman MA, Swaab DF Increased number of vasopressin and oxytocin expressing neurons in the paraventricular nucleus of the human hypothalamus in depression. Arch Gen Psychiatry. 53:1996;137-143.
32. Raadsheer FC, Sluiter AA, Ravid R, Tilders FJH, Swaab DF Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus. Age-dependent cololocalization with vasopressin Brain Res. 615:1993;50-62.
33. Raadsheer F, Hoogendijk WJG, Stam FC, Tilders FJH, Swaab DF Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalaminc paraventricular nucleus of depressed patients. Neuroendocrinology. 60:1994;436-443.
34. Reul JMHM, Stec I, Söder M, Holsboer F Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology. 133:1993;312-320.
35. Reul JMHM, Labeur MS, Grigoriadis DE, De Souza EB, Holsboer F Hypothalamic-pituitary-adrenocortical axis change in rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology. 60:1994;509-519.
36. Richard D, Chapdelaine S, Deshaies Y, Pepin MC, Barden N Energy balance and lipid metabolism in transgenic mice bearing an antisense glucocorticoid receptor gene construct. Am J Physiol. 265:1993;R146-150.
37. Sadovnick AD, Remick RA, Lam R, Zis AP, Yee IML, Huggins MJ, Baird PA Mood Disorder Service Genetic Database. Morbidity risks for mood disorders in 3942 first-degree relatives of 671 index cases with single depression, recurrent depression, bipolar I, or bipolar II Am J Med Genetics. 54:1994;132-140.
38. Sulz SKD Das Verhaltensdiagnostik-System VDS. Von der Anamnese zum Therapieplan; Problemanalyse, Zielanalyse, Therapieplan:1992;P-Medien, München, CI.
39. Trapp T, Rupprecht R, Castren M, Lombes M, Reul JMHM, Holsboer F Heterodimerization between mineralocorticoid and glucoccorticoid receptor. A new principle of glucocorticoid action in the central nervous system Neuron. 13:1994;1-6.
40. Truss M, Beato M Steroid hormone receptor. Interaction with deoxyribonucleic acid and transcription factors Endocr Rev. 14:1993;460-479.
41. Weisman MM, Gershon ES, Kidd KK, Prusoff BA, Leckmann JF, Dibble E, Hamovit J, Thompson WD, Pauls DL, Guroff JJ Psychiatric disorders in the relatives of probands with affective disorders. The Yale University-National Institute of Mental Health collaborative study Arch Gen Psychiatry. 41:1984;13-21.
42. Wender PE, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, Lunde I Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorder. Arch Gen Psychiatry. 43:1986;923-929.
43. Wittchen HU, Zaudig M, Schramm E, Spengler P, Mombur W, Klug J, Horn R SKID, Strukturiertes Klinisches Interview für DSM-III-R. 1990;Beltz, Weinheim.